Literature DB >> 6721023

The benefits of comprehensive care of hemophilia: a five-year study of outcomes.

P S Smith, P H Levine.   

Abstract

Eleven of 22 federally funded Comprehensive Hemophilia Centers have collected data on outcomes, before and after five years of this program's existence. Improved health, decreased hospitalization, decreased absenteeism, and a decrease in the unemployment rate from 36 per cent to 13 per cent were accompanied by decreased costs of care. In this model of a chronic handicapping illness, the early application of comprehensive care is preferable to the previous emphasis on end-stage rehabilitative efforts.

Entities:  

Mesh：

Year:  1984        PMID： 6721023      PMCID： PMC1651643          DOI： 10.2105/ajph.74.6.616

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  4 in total

1.  The social and economic impact of hemophilia--a survey of 70 cases in Vermont and New Hampshire.

Authors:  R D Meyers; W Adams; K Dardick; J Reinisch; F Von Reyn; T Renna; O R McIntyre
Journal:  Am J Public Health       Date:  1972-04       Impact factor: 9.308

2.  Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program.

Authors:  P S Smith; N C Keyes; E N Forman
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

3.  Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B.

Authors:  P H Levine; A F Britten
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

4.  Delivery of health care in hemophilia.

Authors:  P H Levine
Journal:  Ann N Y Acad Sci       Date:  1975-01-20       Impact factor: 5.691
  4 in total
  12 in total

1.  Assessment of Musculoskeletal Function and its Correlation with Radiological Joint Score in Children with Hemophilia A.

Authors:  Samriti Gupta; Kapil Garg; Jagdish Singh
Journal:  Indian J Pediatr       Date:  2015-05-08       Impact factor: 1.967

2.  Paediatric hereditary angioedema: a survey of UK service provision and patient experience.

Authors:  N Read; E Lim; M D Tarzi; P Hildick-Smith; S Burns; K J Fidler
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders.

Authors:  Judith R Baker; Sally O Crudder; Brenda Riske; Val Bias; Ann Forsberg
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

Review 4.  Care models in the management of haemophilia: a systematic review.

Authors:  C H T Yeung; N Santesso; M Pai; C Kessler; N S Key; M Makris; T Navarro-Ruan; J M Soucie; H J Schünemann; A Iorio
Journal:  Haemophilia       Date:  2016-07       Impact factor: 4.287

Review 5.  Treatment strategies in children with hemophilia.

Authors:  Pia Petrini
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.

Authors: 
Journal:  CMAJ       Date:  1995-07-15       Impact factor: 8.262

Review 7.  Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.

Authors: 
Journal:  CMAJ       Date:  1995-07-01       Impact factor: 8.262

8.  Haemophilia in the developing countries: the Iranian experience.

Authors:  Peyman Eshghi; Mitra Mahdavi-Mazdeh; Mehran Karimi; Mohammad Aghighi
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

9.  First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.

Authors:  A N Traore; A K C Chan; K E Webert; N Heddle; B Ritchie; J St-Louis; J Teitel; D Lillicrap; A Iorio; I Walker
Journal:  Haemophilia       Date:  2014-07       Impact factor: 4.287

10.  Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran.

Authors:  Mehran Karimi; Tahereh Zarei; Sezaneh Haghpanah; Zohreh Zahedi
Journal:  Turk J Haematol       Date:  2016-06-17       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.